Location History:
- Nes Ziona, IL (2014 - 2018)
- Nes Zionna, IL (2014 - 2020)
Company Filing History:
16 out of 67 
3 out of 3,868 
2 out of 1,579 
Years Active: 2014-2020
Title: The Innovative Work of Sharon Avkin-Nachum in Gene Therapy
Introduction: Sharon Avkin-Nachum, based in Nes Zionna, IL, is a distinguished inventor recognized for his contributions to the field of nucleic acids and gene therapy. With an impressive portfolio of 21 patents, Avkin-Nachum has pioneered advances that hold promise for treating various diseases and disorders through innovative technology.
Latest Patents: Among his most recent patent filings are "Double-stranded oligonucleotide molecules targeting p53 and methods of use thereof," which involves chemically synthesized nucleic acid compounds designed to down-regulate the expression of the p53 gene. This invention expands the possibilities for treating a range of conditions linked to gene expression. Another notable patent is focused on "siRNA compounds comprising terminal substitutions," which relates to modified small interfering RNA (siRNA) compounds that also aim to down-regulate target gene expression. This innovative approach contributes to pharmaceutical compositions that are geared toward treating and preventing severities of diseases related to specific genes.
Career Highlights: Throughout his career, Sharon Avkin-Nachum has worked with prominent companies such as Quark Pharmaceuticals, Inc. and Nitto Denko Corporation. His efforts within these organizations have been vital for advancing therapeutic applications in genetic research. His extensive experience in biotechnology has cultivated a robust understanding of creating valuable solutions drawn from cutting-edge research.
Collaborations: Avkin-Nachum has collaborated with notable colleagues including Elena Feinstein and Hagar Kalinski. These partnerships have fostered an environment of innovation, facilitating the exchange of ideas and enabling the development of groundbreaking technologies in the realm of molecular biology and gene therapy.
Conclusion: Sharon Avkin-Nachum's innovative spirit and dedication to advancing the field of gene therapy are evident in his numerous patents and collaborative efforts. His work showcases the critical role of creativity and scientific inquiry in addressing complex health challenges. As the field of biotechnology continues to evolve, the contributions of inventors like Avkin-Nachum will undoubtedly pave the way for new discoveries and treatments.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.